2-O, 3-O desulfated heparin for the prevention of GVHD
Research Grant
Administered By
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
Cantex Pharmaceuticals, Inc.
Start Date
June 25, 2015
End Date
June 30, 2017
Administered By
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
Cantex Pharmaceuticals, Inc.
Start Date
June 25, 2015
End Date
June 30, 2017